title: Primary Parotid Lymphoma From A Regional Cancer Center in South India.
abstract: Primary parotid lymphoma (PPL) is an unusual entity and there is limited data in Indian population. Hence we undertook this retrospective observational study of primary parotid lymphoma at our Center in Southern India. This study includes 7 consecutive cases diagnosed as PPL by tissue biopsy/superficial/deep parotidectomy confirmed by immunohistochemistry between January 2007 and December 2012.
  
  
  RESULTS
  Median age was 54 years (range 29- 78 years), and it was more common in males. According to Ann Arbor stage, Advanced stage (stage III and IV) was seen in 2 (28.57%). According to the International Prognostic Index (IPI), most (6) were low risk (85.7%). Overall survival ranged from 1-45 months with median OS of 18 months. To conclude, PPL presents more often in early stage and low IPI score. Surgery +/- chemoimmunotherapy with radiotherapy to the parotid is the standard treatment at present.
authors.affiliation: Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bangalore, Karnataka, India.
authors.forename: B K
authors.initials: BK
authors.lastname: Govind
authors.affiliation: Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bangalore, Karnataka, India.
authors.forename: K C
authors.initials: KC
authors.lastname: Lakshmaiah
authors.affiliation: Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bangalore, Karnataka, India.
authors.forename: D
authors.initials: D
authors.lastname: Lokanatha
authors.affiliation: Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bangalore, Karnataka, India.
authors.forename: B
authors.initials: B
authors.lastname: Suresh
authors.affiliation: Department of Pathology, Kidwai Memorial Institute of Oncology, Bangalore, India.
authors.forename: C S
authors.initials: CS
authors.lastname: Premalata
authors.affiliation: Department of Pathology, Kidwai Memorial Institute of Oncology, Bangalore, India.
authors.forename: C R
authors.initials: CR
authors.lastname: Rao
authors.affiliation: Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bangalore, Karnataka, India.
authors.forename: L J
authors.initials: LJ
authors.lastname: Abraham
authors.affiliation: Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bangalore, Karnataka, India.
authors.forename: K N
authors.initials: KN
authors.lastname: Lokesh
authors.affiliation: Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bangalore, Karnataka, India.
authors.forename: L K
authors.initials: LK
authors.lastname: Rajeev
authors.affiliation: Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bangalore, Karnataka, India.
authors.forename: V
authors.initials: V
authors.lastname: Arroju
authors.affiliation: Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bangalore, Karnataka, India.
authors.forename: V
authors.initials: V
authors.lastname: Sathyanarayanan
mesh_terms: D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D007194:India; D008223:Lymphoma / Q000453:epidemiology* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D010307:Parotid Neoplasms / Q000453:epidemiology* / Q000473:pathology; D011379:Prognosis; D012189:Retrospective Studies